MedPath

POLYSAN Scientific & Technological Pharmaceutical Company

Ownership
Private
Employees
-
Market Cap
-
Website

Study of Safety and Tolerability of UNIFUZOL (Solution for Infusions) in Healthy Volunteers

Phase 1
Completed
Conditions
Peripheral Vascular Disease
Interventions
First Posted Date
2017-01-23
Last Posted Date
2020-07-14
Lead Sponsor
POLYSAN Scientific & Technological Pharmaceutical Company
Target Recruit Count
48
Registration Number
NCT03028285
Locations
🇷🇺

Clinical diagnostic laboratory of City Clinical Hospital named after I.V.Davydovsky, Moscow, Russian Federation

🇷🇺

Research Center for Eco-safety, Ltd., Saint Petersburg, Russian Federation

Runihol in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome

Phase 2
Terminated
Conditions
Non-alcoholic Fatty Liver Disease
Interventions
Other: Placebo
First Posted Date
2016-10-12
Last Posted Date
2019-02-08
Lead Sponsor
POLYSAN Scientific & Technological Pharmaceutical Company
Target Recruit Count
35
Registration Number
NCT02930161
Locations
🇷🇺

Medical Company "Hepatologist" Ltd., Samara, Russian Federation

🇷🇺

Company "Clinic of professor Gorbakov" Ltd., Krasnogorsk, Russian Federation

🇷🇺

City Hospital of the Holy Martyr Elizabeth, Saint-Petersburg, Russian Federation

© Copyright 2025. All Rights Reserved by MedPath